35.47
price up icon5.38%   1.81
after-market Handel nachbörslich: 34.51 -0.96 -2.71%
loading

Atricure Inc Aktie (ATRC) Neueste Nachrichten

pulisher
03:56 AM

AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com

03:56 AM
pulisher
Nov 03, 2024

Emerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

US$42.67That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results - Simply Wall St

Nov 01, 2024
pulisher
Oct 31, 2024

AtriCure, Inc. (NASDAQ:ATRC) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

AtriCure Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)? - Simply Wall St

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: AtriCure reports robust growth, raises full-year guidance By Investing.com - Investing.com Nigeria

Oct 31, 2024
pulisher
Oct 30, 2024

Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure price target raised to $36 from $32 at Oppenheimer - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure (NASDAQ:ATRC) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Canaccord raises AtriCure stock outlook, noting growth in pain management and open ablation - Investing.com India

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure (NASDAQ:ATRC) Shares Gap Up Following Strong Earnings - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure (NASDAQ:ATRC) Given New $40.00 Price Target at Needham & Company LLC - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure, Inc. (NASDAQ:ATRC) Short Interest Down 8.4% in October - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure Reports Strong Growth in Q3 2024 Earnings - TipRanks

Oct 30, 2024
pulisher
Oct 30, 2024

AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

AtriCure: Q3 Earnings Snapshot - The Washington Post

Oct 29, 2024
pulisher
Oct 29, 2024

AtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings Guidance - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Oct 29, 2024
pulisher
Oct 29, 2024

AtriCure Inc (ATRC) Q3 2024 Earnings: Revenue Surpasses Estimates at $115.9 Million, Net Loss Per Share at $0.17 - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

AtriCure Reports Third Quarter 2024 Financial Results - StockTitan

Oct 29, 2024
pulisher
Oct 29, 2024

Assenagon Asset Management S.A. Purchases 138,046 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

AtriCure to Participate in the UBS Global Healthcare Conference - StockTitan

Oct 28, 2024
pulisher
Oct 26, 2024

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Oct 26, 2024
pulisher
Oct 22, 2024

AtriCure (ATRC) Scheduled to Post Earnings on Tuesday - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Cardiac Ablation Technology Market Analysis By Top Keyplayers - openPR

Oct 21, 2024
pulisher
Oct 20, 2024

(ATRC) Long Term Investment Analysis - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 17, 2024

AtriCure Inc (ATRC) Trading Down 2.91% on Oct 17 - GuruFocus.com

Oct 17, 2024
pulisher
Oct 17, 2024

SG Americas Securities LLC Buys New Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management - BioSpace

Oct 16, 2024
pulisher
Oct 15, 2024

AtriCure launches new CryoSphere Max cryoablation probe - Mass Device

Oct 15, 2024
pulisher
Oct 13, 2024

Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago - Yahoo Finance

Oct 13, 2024
pulisher
Oct 11, 2024

AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

Atrial Fibrillation Market Rapid Growth, Challenges, - openPR

Oct 11, 2024
pulisher
Oct 10, 2024

Atrial Appendage Occluder Market Set to Soar to USD 8,193.0 Million by 2033 at a 23.6% of CAGR - Future Market Insights

Oct 10, 2024
pulisher
Oct 10, 2024

Is Atricure Inc (ATRC) a threat to investors? - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

Transcatheter Embolization and Occlusion Devices Market Analysis To 2031 | Inc, AtriCure, Stryker Corporation, Merit Medical System, Pfizer, Inc, Edwards – Times-BD24 - Times-BD24

Oct 10, 2024
pulisher
Oct 09, 2024

Where are the Opportunities in (ATRC) - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 08, 2024

There is no doubt that Atricure Inc (ATRC) ticks all the boxes. - SETE News

Oct 08, 2024
pulisher
Oct 08, 2024

Market Insight: Atricure Inc (ATRC)’s Notable Drop, Closing at 27.07 - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

Atrial Fibrillation Market Growth Analysis with Investment Opportunities For 2024-2033 - EIN News

Oct 08, 2024
pulisher
Oct 08, 2024

AtriCure to Announce Third Quarter 2024 Financial Results - StockTitan

Oct 08, 2024
pulisher
Oct 06, 2024

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Oct 06, 2024
pulisher
Oct 05, 2024

Millennium Management LLC Has $21.69 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Oct 05, 2024
$22.77
price up icon 0.98%
$212.15
price up icon 0.65%
medical_instruments_supplies BAX
$36.10
price up icon 0.84%
$78.80
price down icon 5.88%
medical_instruments_supplies COO
$105.21
price up icon 0.33%
medical_instruments_supplies WST
$323.47
price up icon 2.76%
Kapitalisierung:     |  Volumen (24h):